Trials / Sponsors / Verismo Therapeutics
Verismo Therapeutics
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Cancer | — | 2025-01-27 |
| Recruiting | SynKIR-310 for Relapsed/Refractory B-NHL B Cell Lymphoma, NHL, Adult, Mantle Cell Lymphoma | Phase 1 | 2024-11-01 |
| Withdrawn | Long-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer Studies Cancer | — | 2023-11-15 |
| Recruiting | SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma Ovarian Cancer, Cholangiocarcinoma Recurrent, Mesothelioma, Malignant | Phase 1 | 2023-03-30 |